CommentSecondary brain injury after aneurysmal subarachnoid haemorrhage: more than vasospasm
References (11)
- et al.
Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage
Lancet Neurol
(2011) - et al.
Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage
Lancet Neurol
(2010) - et al.
Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution
Nat Clin Pract Neurol
(2007) - et al.
Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function
J Neurosurg
(2007) - et al.
Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study
J Neurosurg
(2005)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2011 Elsevier Ltd. All rights reserved.